The Clinical Utility of the Genomic Prostate Score in Men with Very Low to Intermediate Risk Prostate Cancer

Christopher Gaffney, Ron Golan, Miguel D. Cantu, Theresa Scognamiglio, Hiral Mccarthy, Juan Miguel Mosquera, Timothy D. Mcclure, Christopher E. Barbieri, Brian D. Robinson, Francesca Khani

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'The Clinical Utility of the Genomic Prostate Score in Men with Very Low to Intermediate Risk Prostate Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences